VI
AUPH icon

Vestcor Inc’s Aurinia Pharmaceuticals AUPH Stock Holding History

Vestcor Inc’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
119,319
+57,060
+92% +$912K 0.05% 345
2026
Q1 		$923K Buy
62,259
+9,195
+17% +$134K 0.03% 525
2025
Q4 		$846K Sell
53,064
-10,334
-16% -$146K 0.02% 539
2025
Q3 		$701K Sell
63,398
-26,418
-29% -$289K 0.02% 608
2025
Q2 		$761K Buy
+89,816
New +$720K 0.02% 569

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's AUPH Position: Q2 2026 in Review

Vestcor Inc increased its Aurinia Pharmaceuticals (AUPH) stake by 92% in Q2 2026, buying an estimated $912K and bringing the position to 119,319 shares worth $2.02M. The position accounts for 0.05% of the portfolio, ranked #345.

Vestcor Inc first reported a position in AUPH in Q2 2025 and has held it in 5 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Vestcor Inc held 119,319 shares of Aurinia Pharmaceuticals worth $2.02M as of Q2 2026.
  • Vestcor Inc bought 57,060 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $912K.
  • Aurinia Pharmaceuticals made up 0.05% of Vestcor Inc's portfolio in Q2 2026, its #345 holding.
  • Vestcor Inc first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.